Bioprocessing solutions and excipients for protein therapeutic formulations

Bioprocessing solutions and excipients for protein therapeutic formulations
Product Description

From excipients for protein therapeutic formulations, to innovating solutions for bioprocessing, we have decades of experience in protein delivery. TALK TO US about our latest launches: Virodex™ detergent range, a sustainable alternative to Triton™ X-100 for viral inactivation and cell lysis. Plus, Tween™ 20 HP LSA - A highly purified polysorbate 20 that has been designed to reduce the risk of free fatty acid particle formation. Solutions for bioprocessing We leverage our expertise in biotechnology to provide cutting-edge solutions for the bioprocessing of protein-based therapies, including monoclonal antibodies and other recombinant proteins. With our vast portfolio of high purity chemicals, we provide bioprocessing solutions that enable efficient and effective production of biologic drugs. Our offerings in bioprocessing include chemicals for viral inactivation and cell lysis, meeting the needs of applications such as the biomanufacturing of plasma-derived or blood fractionation therapies, recombinant protein therapeutics, viral vector-based therapies, and more. Excipients for protein therapeutic formulations We understand the challenges faced by protein therapy manufacturers in developing formulations that maintain their stability and efficacy, such as protein aggregation. We develop high-quality excipients specifically designed to improve the stability, solubility and bioavailability of protein therapeutics. Our Super Refined™ excipients are manufactured to the highest standards of purity and quality, and undergo rigorous testing to ensure they meet the strict regulatory requirements expected for the parenteral administration route.

Croda pharma

  • GB
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Fine Chemicals Company

Croda pharma

  • GB
  • 2015
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Animal Health
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
Fine Chemicals Company

More Products from Croda pharma (26)

  • Super Refined™ L18 POG

    Product Super Refined™ L18 POG

    Super Refined™ L18 POG:Super Refined™ L18 POG is a high purity mixture of mono-, di-, and triesters of glycerol, and mono- and diesters of polyethylene glycols, with the predominant fatty acid concentration stemming from linoleic acid. It is a low HLB emulsifier and solubiliser of poorly water soluble Acti...
  • Super Refined™ O18 POG

    Product Super Refined™ O18 POG

    Super Refined™ O18 POG:Super Refined™ O18 POG is a high purity mixture of mono-, di-, and triesters of glycerol, and mono- and diesters of polyethylene glycols with the predominant fatty acid concentration stemming from oleic acid. It is a low HLB emulsifier and solubiliser of poorly water soluble Active P...
  • Super Refined™ PEG 300

    Product Super Refined™ PEG 300

    Super Refined™ PEG 300:Super Refined PEGs are solvents for use with the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes polar impurities (including primary and secondary oxidation products) from an excipient without altering its chemical compositi...
  • Super Refined™ PGML

    Product Super Refined™ PGML

    Super Refined™ PGML:Super Refined™ PGML is a high purity mixture of propylene glycol and esters of lauric (C12) acid. More specifically, as part of the Type II classification, it has at least a 90% concentration of monoesters, with the remaining percentage being diesters. In addition to being a low HLB emu...
  • Tween™ 80 HP

    Product Tween™ 80 HP

    Tween™ 80 HP: • Tween™ 80 HP goes beyond standard polysorbate monograph requirements to provide a low moisture, low peroxide version of Tween 80 designed for parenteral applications and applications where API stability presents a challenge • O/W emulsifier, solubiliser and wetting agent • An additional h...
  • Adjuvant Systems for Vaccines

    Product Adjuvant Systems for Vaccines

    We enable next-generation vaccine development through a diverse portfolio of world-leading vaccine adjuvants, immunomodulators and adjuvant formulations.
    We passionately develop new adjuvant technologies and partner to develop the vaccines of tomorrow.
    Our extensive expertise in immunology and fo...
  • Excipients for Consumer Health

    Product Excipients for Consumer Health

    Croda Pharma's Consumer Health offering combines our technical expertise with regulatory knowledge to help our customers market innovative products with consumer relevant claims, alongside supporting formulation development challenges within the Consumer Health market.
    Our excipient solutions support ...
  • High purity excipients for small molecule delivery

    Product High purity excipients for small molecule delivery

    We offer high purity, multi-compendial, pharmaceutical excipients for small molecule drug delivery. Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms. We are market le...
  • Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

    Product Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics

    Avanti Polar Lipids, part of Croda Pharma, develops innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
    We develop and manufacture highly specialised lipids used in Lipid Nanoparticle (LNP) deliv...
  • Excipient: Super Refined™ PEG 400

    Product Excipient: Super Refined™ PEG 400

    Super Refined PEGs are solvents for use with the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes polar impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, reducing excipi...
  • Excipient: Super Refined™ Polysorbate 80

    Product Excipient: Super Refined™ Polysorbate 80

    Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to red...
  • Excipient: Super Refined™ Polysorbate 20

    Product Excipient: Super Refined™ Polysorbate 20

    Super Refined Polysorbates solubilise and stabilise the most sensitive active ingredients across dosage forms including injectable and oral. Super Refining removes impurities (including primary and secondary oxidation products) from an excipient without altering its chemical composition, helping to red...

Croda pharma resources (2)

  • News Two new partnerships to drive sustainable delivery systems for the pharmaceutical industry

    Croda International Plc (Croda) today announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants. 
  • Brochure Addressing the challenges of vaccine formulation

    To this day, our focus has been to successfully develop, manufacture and market high-quality adjuvants for our pharmaceutical customers. This heritage makes our vaccine adjuvants unique in the industry. A heritage we are proud of. 

    Our industry-leading, Alhydrogel®, Adju-Phos® and Quil-A® are widely recognised in the vaccine industry for their unmatched track record when it comes to a proven history of safe and effective use.